Abstract
Purpose: Preoperative concomitant chemoradiotherapy is the standard of care for ≥T3 or node positive disease rectal cancer. Additionally, high-dose-rate (HDR) endorectal brachytherapy can effectively downstage rectal cancers, resulting in both increased local control and sphincter preservation for lower one-third tumors. We report our initial experience using HDR endorectal brachytherapy as a boost after EBRT for rectal cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
